We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $661B Turnover 17.31%
1-Year Est. Return 35.87%
 

UBS AM is the US asset manager of UBS and grew out of Brinson Partners, an investment firm founded by Gary Brinson and made independent in 1989. Swiss Bank Corporation bought Brinson Partners in 1994, and once the bank merged with UBS, its founder Gary Brinson, who had run Swiss Bank's asset management business, became chief investment officer of UBS Asset Management. In 2024 the business took in Credit Suisse Asset Management and two of its own units, UBS Hedge Fund Solutions and UBS O’Connor, though the O’Connor business was later sold. Its clients are mainly institutions such as retirement plans, government bodies, endowments and foundations.

This Fund
S&P 500
This Quarter Est. Return
+5.21%
1 Year Est. Return
+35.87%
3 Year Est. Return
+147.27%
5 Year Est. Return
+174.93%
10 Year Est. Return
+646.65%
AUM
$99B
AUM Growth
+$5.31B
Cap. Flow
-$321M
Cap. Flow %
-0.32%
Top 10 Hldgs %
14.08%
Holding
2,651
New
81
Increased
1,135
Reduced
556
Closed
97
Avg Time Held
0.9 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
0.9 years

Sector Composition

Rank Sector Weight
1 Healthcare 14.37%
2 Technology 14.2%
3 Financials 14.02%
4 Energy 9.66%
5 Industrials 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$5.1T
$2.95B 2.98%
126,889,980
+1,305,668
+1% +$27.8M
2013 Q2
4 quarters
GOOG icon
2
Alphabet (Google) Class C
GOOG
$3.41T
$2B 2.02%
69,259,351
+2,117,025
+3% +$57.4M
2013 Q2
4 quarters
XOM icon
3
ExxonMobil
XOM
$681B
$1.69B 1.71%
16,827,405
-45,842
-0.3% -$4.62M
2013 Q2
4 quarters
MSFT icon
4
Microsoft
MSFT
$3.77T
$1.28B 1.3%
30,788,237
+2,571,676
+9% +$104M
2013 Q2
4 quarters
WFC icon
5
Wells Fargo
WFC
$248B
$1.14B 1.15%
21,684,109
-321,640
-1% -$16.2M
2013 Q2
4 quarters
JNJ icon
6
Johnson & Johnson
JNJ
$671B
$1.1B 1.11%
10,511,741
-36,586
-0.3% -$3.7M
2013 Q2
4 quarters
GE icon
7
GE Aerospace
GE
$336B
$1.02B 1.03%
8,071,852
+66,073
+0.8% +$8.4M
2013 Q2
4 quarters
CVX icon
8
Chevron
CVX
$421B
$943M 0.95%
7,224,334
+12,355
+0.2% +$1.54M
2013 Q2
4 quarters
PG icon
9
Procter & Gamble
PG
$399B
$919M 0.93%
11,688,640
+117,112
+1% +$9.44M
2013 Q2
4 quarters
GILD icon
10
Gilead Sciences
GILD
$211B
$901M 0.91%
10,861,868
-364,798
-3% -$28.4M
2013 Q2
4 quarters
JPM icon
11
JPMorgan Chase
JPM
$876B
$888M 0.9%
15,412,331
-527,782
-3% -$29.7M
2013 Q2
4 quarters
SLB icon
12
SLB
SLB
$72.7B
$853M 0.86%
7,234,332
-132,637
-2% -$13.7M
2013 Q2
4 quarters
AMZN icon
13
Amazon
AMZN
$2.78T
$811M 0.82%
49,936,540
+940,020
+2% +$14.9M
2013 Q2
4 quarters
META icon
14
Meta Platforms (Facebook)
META
$1.58T
$727M 0.73%
10,799,231
+544,760
+5% +$33.5M
2013 Q2
4 quarters
T icon
15
AT&T
T
$151B
$719M 0.73%
26,929,273
-292,547
-1% -$7.84M
2013 Q2
4 quarters
IBM icon
16
IBM
IBM
$220B
$718M 0.72%
4,140,803
+255,221
+7% +$45.9M
2013 Q2
4 quarters
PFE icon
17
Pfizer
PFE
$162B
$714M 0.72%
25,353,060
-113,534
-0.4% -$3.24M
2013 Q2
4 quarters
HD icon
18
Home Depot
HD
$339B
$709M 0.72%
8,756,139
+2,714,193
+45% +$214M
2013 Q2
4 quarters
V icon
19
Visa
V
$782B
$703M 0.71%
13,349,880
+1,105,044
+9% +$57.8M
2013 Q2
4 quarters
C icon
20
Citigroup
C
$198B
$692M 0.7%
14,684,147
-624,678
-4% -$29.7M
2013 Q2
4 quarters
CMCSA icon
21
Comcast
CMCSA
$90.7B
$669M 0.68%
24,915,620
-78,968
-0.3% -$2.03M
2013 Q2
4 quarters
PEP icon
22
PepsiCo
PEP
$194B
$643M 0.65%
7,200,801
-169,948
-2% -$14.7M
2013 Q2
4 quarters
BRK.B icon
23
Berkshire Hathaway Class B
BRK.B
$1.26T
$643M 0.65%
5,078,343
+49,554
+1% +$6.27M
2013 Q2
4 quarters
MRK icon
24
Merck
MRK
$354B
$623M 0.63%
11,279,815
-1,380,587
-11% -$75.3M
2013 Q2
4 quarters
VZ icon
25
Verizon
VZ
$191B
$616M 0.62%
12,591,792
+321,298
+3% +$15.6M
2013 Q2
4 quarters

Similar funds

UBS AM's Q2 2014 Portfolio in Review

As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Technology and Financials.

  • UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
  • UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
  • UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
  • UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
  • UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
  • UBS AM opened 81 new positions and closed 97 in Q2 2014.
  • UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.

Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.